Archives

July 28, 2024 (Philadelphia, PA) Our team presented a variety of new research findings at this conference, the largest forum in the world for the dementia research community. Our team’s [...]

July 10, 2024 Dr. Dickerson participated in a PBS News Hour interview about his perspective on cognitive function in presidential candidates. Dr. Dickerson said “it is very difficult to separate [...]

Today the U.S. Food and Drug Administration approved donanemab for the treatment of people living with early symptomatic Alzheimer’s disease, which includes mild cognitive impairment and the mild [...]